Can wearable ECG monitors detect atrial fibrillation early?

How accurate are wearable ECG monitors for detecting atrial fibrillation?

Overall, wearable ECG monitors are highly accurate. A 2025 meta-analysis of 26 studies (17,349 patients) reported a pooled sensitivity of 95% and specificity of 97% for AF detection, meaning they correctly identify AF in 19 out of 20 people who have it and correctly rule it out in 97 out of 100 who don't [2]. Another review found sensitivity ranging from 93% to 98% across studies [3]. However, accuracy varies by device and whether the reading is automated or interpreted by a doctor. For example, the Masimo W1 wrist-wearable achieved 99.3% sensitivity and 100% specificity in a 356-patient study [4], while the Withings Scanwatch's automated algorithm had only 76% sensitivity (though cardiologist review of the same tracings raised it to 97%) [10]. The Apple Watch showed 94% sensitivity and 97% specificity in the meta-analysis [2], but in a real-world post-ablation monitoring study, its automated AF label had 71% sensitivity (though 96% specificity) [9]. The key takeaway: automated alerts are a good first pass, but a doctor's review of the ECG waveform is often needed for a reliable diagnosis.

Yes, and that's one of their biggest advantages. Many AF episodes are asymptomatic—people don't feel palpitations or shortness of breath—so they can go undiagnosed until a stroke occurs. Wearable monitors can detect these 'silent' episodes. In the Fitbit Heart Study (over 455,000 participants), after an initial irregular rhythm alert from the wrist-worn device, longer ECG monitoring (e.g., a 2-week patch) confirmed AF in nearly half of cases (46.8%) [1]. Another study using a patch-type ECG monitor after heart attack found that 56% of patients had brief, asymptomatic atrial tachycardia episodes that would have been missed by a standard 24-hour Holter monitor [6][7]. A 2025 study on a lightweight AI model for wearable ECG data achieved 97.1% specificity and 96.9% accuracy over 7-day recordings, showing that continuous monitoring can reliably pick up AF even when it comes and goes [8]. The bottom line: wearables can detect AF early—often before you or your doctor would notice—which is critical because early treatment can reduce stroke risk.

What are the limitations? False alarms, inconclusive readings, and the need for clinical confirmation

Despite high accuracy, wearable ECGs have important limitations. False positives (alerts that say AF when it's not) can cause anxiety and unnecessary doctor visits. One review noted that false-positive rates remain high, with 15% of users reporting anxiety from alerts [3]. In the Fitbit Heart Study, only 7.6% of initial irregular rhythm alerts were confirmed as AF by a single 10-second ECG, though longer monitoring increased confirmation rates [1]. Inconclusive readings are also common: the Withings Scanwatch couldn't classify 14% of recordings automatically, though cardiologists could interpret most of them [10]. Motion artifacts and noise are a problem, especially with patch-type monitors that record for days—one study found higher noise rates with patch devices compared to lead-type monitors [5]. Finally, automated algorithms can miss AF (false negatives). In the Apple Watch post-ablation study, 55% of 'inconclusive' or 'high heart rate' readings were actually AF when reviewed by experts [9]. The practical advice: if your wearable alerts you to possible AF, don't panic—but do follow up with a doctor who can review the actual ECG tracing and, if needed, order confirmatory monitoring.

About These Sources

This answer is built on 10 peer-reviewed studies — published from 2021 to 2026, 7 from 2024 or later, 4 in Q1 journals — selected as the most relevant from 15 studies that passed quality screening, drawn from 73 papers retrieved from a database of over 500 million.

Sources used in this answer

Related research questions